Spectral Medical Inc T.EDT

Assuming the current pace is maintained....

[mercedesman]

Assuming the current pace is maintained...of just 5/month ....

That acheives 90 in six months (30/5) or before the end of November of this year !  Interim data release is at patient 90 where Baxter decides whether to continue to fund the Tigris Trial (with another $ 5M? $ 10M? infusion).  One has to wonder why they would not, given results are (greatly?) exceeding expecttaions, and the fact that they have already put in $ 10M USD, the only Analyst assumes 100% liklihood of FDA approval, and thta baxter is featuring PMX/EAA in their KidneyCo teaser, and they are spending money on marketing materilals so that they can hit the ground running.

Assuming the Trail is not stopped at 90 (Spectral Mgt says it won't be...but I wonder how the FDA feels about it?) - when would the Trial finish - worst case ? 

If the pace stays the same and they go from 16 sites (current) to 25 shortly (paperwork in the works now) ...that's approx 8 per month (5 x 25/16) - which is the same current pace per site, just with more sites.

So starting in December, in order to complete the trial (150) at a pace of 8 per month (ie. an extra 60 patients) they would  need an additional 7.5 months.   That's roughly a completion by June 2024 !

Or if the pace picked up by say 2 per month (to 10/month) as a result of the newly established momentum resultling from new CRO, Investigator meeting, videos, etc. it would take only 6 months - or say May 2024 to get to 150.

12/month would be April 2024...and so on.

Exciting times ahead for Spectral shareholders !

MM


PS  Now would be a good time to introduce more US investors to Spectral, don't you think?

[Stocktree]

[Accountprince]

Treeboy - now you're posting a selfie of yourself?  At least it helps to back up what we've all thought about you.  As they say a picture is worth a thousand words.  

[mercedesman]

Is this what you mean when you said about the role of a poster .... "I think it is to discuss the pros and cons of an investment." lol   You're a joke and strictly a "con"man.

[Stocktree]

The conman is he who still bases his expectations on an "analyst" business who claimed 2 years ago we would soon be in the $4 range and who now expects us to believe the success of the trial is 100% guaranteed, while no one at Spectal would dare to venture anywhere nead this territory. But keep pumping, mayble you will bring the stock up to a whapping 33 cents and you will then be able

[mercedesman]

I'm not trying to bring the price up...to .33 or whatever.   I preferred accumulating in the .20's, but may up that buy price, if the pace of enrolment keeps on impressing. I'm just trying to point out the extreme undervaluation - to those that are prepared to act...and believe the end-game is upon us. It's Seto (and the BoD?)  that appears to be choosing not to

[oilandgasman]

You know the price history here. Why would you would even consider buying in the 30's is beyond me McShill.